tiprankstipranks

JOHN ABALLI Insider Profile

4 Followers
JOHN ABALLI, President & CEO, Director at Exagen, holds 689.80K shares in Exagen (Ticker: XGN). Most recently, JOHN ABALLI Bought $24,305 shares of Exagen on Nov 18, 2024 for an estimated value of 68.30K.
tipranks
JOHN ABALLI

JOHN ABALLI
Exagen (XGN)
President & CEO, Director

Ranked #17,328 out of 99,635 Corporate Insiders

Profitable Transactions

50%
2 out of 4 Profitable Transactions

Average Return

+27.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
100.00%
A breakdown of JOHN ABALLI's holdings

Insider Roles

Exagen
(XGN)
President & CEO, Director
Roles that JOHN ABALLI holds in companies

Most Profitable Insider Trade

Stock:
Exagen
(XGN)
Rating:Informative Buy
Date:May 16, 2024 - Today
Return:+116.90%
The most profitable trade made by JOHN ABALLI

JOHN ABALLI's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Exagen
Nov 18, 2024
President & CEO, Director
Informative Buy
68.30K
$2.79M
Success Rate for
XGN
2 out of 4 profitable transactions on
XGN
50%
Average Return for
XGN
Average return per transaction on
XGN
+27.93%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Oct 18, 2022
Uninformative Buy
$0.00
-
$0.00
Dec 09, 2022
Informative Buy
$241.20K
-
$2.68
-35.10%
Sep 06, 2023
Uninformative Buy
$20.98K
-
$2.14
Feb 22, 2024
Uninformative Buy
$0.00
-
$0.00
Mar 04, 2024
Uninformative Buy
$18.73K
-
$1.91
List of latest transactions for each holding click on a transaction to see JOHN ABALLI's performance on stock

JOHN ABALLI insider profile FAQ

What is the percentage of profitable transactions made by JOHN ABALLI?
The percentage of profitable transactions made by JOHN ABALLI is 50%.
    What is the average return per transaction made by JOHN ABALLI?
    The average return per transaction made by JOHN ABALLI is 27.90%.
      What stocks does JOHN ABALLI hold?
      JOHN ABALLI holds: XGN stocks.
        What was JOHN ABALLI’s latest transaction?
        JOHN ABALLI latest transaction was an Informative Buy of $68.30K.
          What was JOHN ABALLI's most profitable transaction?
          JOHN ABALLI’s most profitable transaction was an Informative Buy of XGN stock on May 16, 2024. The return on the trade was 116.90%.
            What is JOHN ABALLI's role in Exagen?
            JOHN ABALLI's role in Exagen is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.